Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis (Q36203962)

12 August 2017

1 reference

title

Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis (English)

1 reference

12 August 2017

2

Barry I Hudson

1 reference

12 August 2017

15

Kevan Herold

1 reference

12 August 2017

17

Ann Marie Schmidt

1 reference

12 August 2017

William Kim

1

1 reference

12 August 2017

Bernhard Moser

3

1 reference

12 August 2017

Jiancheng Guo

4

1 reference

12 August 2017

Ling Ling Rong

5

1 reference

12 August 2017

Yan Lu

6

1 reference

12 August 2017

Wu Qu

7

1 reference

12 August 2017

Evanthia Lalla

8

1 reference

12 August 2017

Shulamit Lerner

9

1 reference

12 August 2017

Yali Chen

10

1 reference

12 August 2017

Shirley Shi Du Yan

11

1 reference

12 August 2017

Vivette D'Agati

12

1 reference

12 August 2017

Yoshifumi Naka

13

1 reference

12 August 2017

Ravichandran Ramasamy

14

1 reference

12 August 2017

Shi Fang Yan

16

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Annals of the New York Academy of Sciences

12 August 2017

1 reference

12 August 2017

1043

1 reference

12 August 2017

553-561

1 reference

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

12 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

The S100 family of EF-hand calcium-binding proteins: functions and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

The S100 protein family: history, function, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.063

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1338.063

1 reference

12 August 2017

1 reference